|
Quotes & Info
|
| OMER > SEC Filings for OMER > Form 8-K on 18-Jun-2012 | All Recent SEC Filings |
18-Jun-2012
Change in Directors or Principal Officers
On June 14, 2012, Daniel K. Spiegelman delivered written notice of his resignation from our board of directors effective as of June 21, 2012. Mr. Spiegelman resigned in connection with his appointment as chief financial officer of a publicly traded biopharmaceutical company.
|
|